Picture of Celldex Therapeutics logo

CLDX — Celldex Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Brief: Celldex Reports Third Quarter 2022 Financial Results

Nov 9 (Reuters) - Celldex Therapeutics Inc  CLDX.O :
    * CELLDEX REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES CORPORATE UPDATE
    * Q3 REVENUE $400,000
    * Q3 LOSS PER SHARE $0.57
    * TOTAL REVENUE WAS $0.4 MILLION IN Q3 OF 2022 COMPARED TO
$0.2
MILLION
    * Q3 EARNINGS PER SHARE VIEW $-0.58, REVENUE VIEW $360000.00
--
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX6KDzPp 
Further company coverage:  CLDX.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Celldex Therapeutics

See all news